Epidemiological insights into Haemophilus influenzae and Pseudomonas aeruginosa persistent colonization in non-cystic fibrosis bronchiectasis patients: a longitudinal and multicenter study
Por:
Cadenas-Jiménez, I, Camps-Massa, P, Gonçalves-Carvalho, F, Benaali-Bakkar, Y, Quero, S, Rodríguez, L, Antuori, A, Saiz-Escobedo, L, Calvo-Silveria, S, Oliver, A, Dominguez, MA, Tubau, F, González-Díaz, A, Ardanuy, C, Santos, S, Marin, A and Martí, S
Publicada:
16 feb 2026
Resumen:
BackgroundBronchiectasis is a chronic respiratory disease characterized by recurrent exacerbations and persistent inflammation, often associated with bacterial pathogens such as Haemophilus influenzae and Pseudomonas aeruginosa. Phenotypic adaptations (e.g., antimicrobial resistance) complicate treatment and worsen a patient's quality of life.MethodsBetween 2019 and 2020, we isolated 52 H. influenzae and 48 P. aeruginosa strains from 62 non-CF bronchiectasis patients across three scheduled visits and during exacerbation episodes. Antimicrobial susceptibility (assessed by microdilution) and phenotyping assays (motility and hypermutability) were performed. Whole genome sequencing was applied for analyses of resistance determinants, virulence factors, and genetic diversity.ResultsOf the 62 patients, 31 were colonized by H. influenzae, 28 by P. aeruginosa, and 3 were co-colonized. Severe disease was predominantly linked to P. aeruginosa (70.6%), while exacerbations were more common with H. influenzae (81.8%). Multilocus sequence typing (MLST) revealed high genetic diversity, with ST1025 and ST253 most common in H. influenzae and P. aeruginosa, respectively. Antimicrobial resistance was low, but H. influenzae showed the highest resistance to cotrimoxazole (40.4%), while P. aeruginosa showed high resistance to aminoglycosides (27.1%) and fluoroquinolones (25%). Virulence profiling of P. aeruginosa identified 22.9% of strains as hypermutable, 27.1% as mucoid, 31.3% harboring the exoU gene, and 41.7% with impaired twitching motility. Persistent colonization occurred in 16 patients (25.8%), with antimicrobial resistance emerging following previous antimicrobial treatment in one case.ConclusionsIn this cohort, H. influenzae and P. aeruginosa showed similar prevalence, high genetic diversity, and rare co-colonization. P. aeruginosa was associated with more severe disease, higher antimicrobial resistance, and hypermutability, whereas H. influenzae was associated with acute exacerbations.
Filiaciones:
Cadenas-Jiménez, I:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain
Camps-Massa, P:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain
Hosp Universitari Bellvitge, Pneumol Dept, IDIBELL UB, Barcelona, Spain
Gonçalves-Carvalho, F:
Hosp Badalona Germans Trias & Pujol, Resp Med Dept, IGTP UAB, Badalona, Spain
Benaali-Bakkar, Y:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
Quero, S:
Hosp Badalona Germans Trias & Pujol, Resp Med Dept, IGTP UAB, Badalona, Spain
:
Hosp Badalona Germans Trias & Pujol, Resp Med Dept, IGTP UAB, Badalona, Spain
Antuori, A:
Hosp Badalona Germans Trias & Pujol, Microbiol Dept, Clin Lab North Metropolitan Area, IGTP UAB, Badalona, Spain
Saiz-Escobedo, L:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain
Calvo-Silveria, S:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain
Oliver, A:
Hosp Son Espases, Microbiol Dept, IdISBa, Palma De Mallorca, Spain
ISCIII, Res Network Infect Dis CIBERINFEC, Madrid, Spain
Dominguez, MA:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain
ISCIII, Res Network Infect Dis CIBERINFEC, Madrid, Spain
Tubau, F:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
González-Díaz, A:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
Ardanuy, C:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
Univ Barcelona, Dept Pathol & Expt Therapeut, Barcelona, Spain
Santos, S:
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
Hosp Universitari Bellvitge, Pneumol Dept, IDIBELL UB, Barcelona, Spain
:
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
Hosp Badalona Germans Trias & Pujol, Resp Med Dept, IGTP UAB, Badalona, Spain
Martí, S:
Hosp Univ Bellvitge, Microbiol Dept, IDIBELL UB, Barcelona, Spain
ISCIII, Res Network Resp Dis CIBERES, Madrid, Spain
Univ Barcelona, Dept Med, Barcelona, Spain
Green Submitted, gold
|